Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: Implications for cellular magnetic resonance imaging

NMR in Biomedicine

Volumn 19, Issue 5, 2006, Pages 581-592

  Pawelczyk, Edyta ^a   Arbab, Ali S ^b   Pandit, Sunil ^a   Hu, Elbert ^a   Frank, Joseph A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Cell labeling; Ferritin; Ferumoxides; Mesenchymal stem cells; Primary macrophages; Protamine sulfate; SPIO; Transferrin receptor (TfR 1)

Indexed keywords

FERRITIN; FERUMOXIDES-PROTAMINE SULFATE LABELING; MACROPHAGES; MESENCHYMAL STEM CELLS; TRANSFERRIN RECEPTOR;

BIOASSAY; CELLS; MAGNETIC RESONANCE IMAGING; METABOLISM; PROTEINS; RNA;

BIOMEDICAL ENGINEERING;

FERRITIN; MESSENGER RNA; PROTAMINE SULFATE; REACTIVE OXYGEN METABOLITE; SUPERPARAMAGNETIC IRON OXIDE; TRANSFERRIN RECEPTOR;

ARTICLE; CELL ASSAY; CELL LABELING; CELL PROLIFERATION; CELL TRANSPORT; CONTROLLED STUDY; GENE EXPRESSION; GENETIC CODE; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; MACROPHAGE; MESENCHYME CELL; MOLECULAR IMAGING; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY; WESTERN BLOTTING;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DEXTRANS; FERRITINS; FERROSOFERRIC OXIDE; HELA CELLS; HUMANS; INDICATORS AND REAGENTS; IRON; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MESENCHYMAL STEM CELLS; OXIDES; PROTAMINES; REACTIVE OXYGEN SPECIES; RECEPTORS, TRANSFERRIN;

EID: 33747359371     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1038     Document Type: Article

References (37)

1. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR Am. J. Roentgenol. 1990; 155: 943-950.
2. Pouliquen D, Le Jeune JJ, Perdrisot R, Ermias A, Jallet P. Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn. Reson. Imaging 1991; 9: 275-283.
3. Yeh TC, Zhang W, Ildstad ST, Ho C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron-oxide particles. Magn. Reson. Med. 1995; 33: 200-208.
4. Kaufman CL, Williams M, Ryle LM, Smith TL, Tanner M, Ho C. Superparamagnetic iron oxide particles transactivator protein-fluorescein isothiocyanate particle labeling for in vivo magnetic resonance imaging detection of cell migration: uptake and durability. Transplantation 2003; 76: 1043-1046.
5. Frank JA, Anderson SA, Kalsih H, Jordan EK, Lewis BK, Yocum GT, Arbab AS. Methods for magnetically labeling stem and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy 2004; 6: 621-625.
6. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Wecker S, Focking M, Arnold H, Hescheler J, Fleischmann BK, Schwindt W, Buhrle C. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl. Acad. Sci. USA 2002; 99: 16267-16272.
7. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Efficient magnetic cell labeling with protamine, sulfate complexed to ferumoxides for cellular MRI. Blood 2004; 104: 1217-1223.
8. Anderson SA, Glod J, Arbab AS, Noel M, Ashad P, Fine HA, Frank JA. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005; 105: 420-425.
9. Daldrup-Link HE, Rudelius M, Oostendorp RA, Jacobs VR, Simon GH, Gooding C, Rummeny EJ. Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX. Acad. Radiol. 2005; 12: 502-510.
10. Dardzinski BJ, Schmithorst VJ, Holland SK, Boivin GP, Imagawa T, Watanabe S, Lewis JM, Hirsch R. MR imaging of murine arthritis using ultrasmall superparamagnetic iron oxide particles. Magn. Reson. Imaging 2001; 19: 1209-1216.
11. Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann. Neurol. 2004; 55: 654-659.
12. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am. J Roentgenol. 1989; 152:167-173.
13. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 1999; 10: 186-191.
14. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 2000; 18: 410-414.
15. Frank JA, Zywicke H, Jordan EK, Mitchell J, Lewis BK, Miller B, Bryant LH, Jr., Bulte JW. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad. Radiol. 2002; 9(Suppl. 2): S484-S487.
16. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH, Jr., Bulte JW. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003; 228: 480-487.
17. Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, Pessanha BS, Guttman MA, Varney TR, Martin BJ, Dunbar CE, McVeigh ER, Lederman RJ. Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. Circulation 2003; 108: 1009-1014.
18. Daldrup-Link HE, Rudelius M, Oostendorp RA, Settles M, Piontek G, Metz S, Rosenbrock H, Keller U, Heinzmann U, Rummeny EJ, Schlegel J, Link TM. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003; 228: 760-767.
19. Kalish H, Arbab AS, Miller BR, Lewis BK, Zywicke HA, Bulte JW, Bryant LH, Jr., Frank JA. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn. Reson. Med. 2003; 50: 275-282.
20. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Response to Letter to the Editor, re ferumoxides-protamine sulfate labeling does not alter differentiation of mysenchymal stem cells. Blood 2004; 104: 3412-3413.
21. Moore A, Basilion JP, Chiocca EA, Weissleder R. Measuring transferrin receptor gene expression by NMR imaging. Biochim. Biophys. Acta 1998; 1402: 239-249.
22. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 2005; 202: 199-211.
23. Crichton RR, Wilmet S, Legssyer R, Ward RJ. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J. Inorg. Biochem. 2002; 91: 9-18.
24. Crichton RR, Ward RJ. An overview of iron metabolism: molecular and cellular criteria for the selection of iron chelators. Curr. Med. Chem. 2003; 10: 997-1004.
25. Aisen P, Enns C, Wessling-Resnick M. Chemistry and biology of eukaryofic iron metabolism. Int. J. Biochem. Cell Biol. 2001; 33: 940-959.
26. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003; 229: 838-846.
27. Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed. 2005; 18: 383-389.
28. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983; 65: 55-63.
30. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 1989; 119: 203-210.
31. Berridge MV, Tan AS. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 1993; 303: 474-482.
32. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, Frank JA. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 2005; 18: 553-559.
33. Bulte JW, Miller GF, Vymazal J, Brooks RA, Frank JA. Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn. Reson. Med. 1997; 37: 530-536.
34. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 2001; 19: 1141-1147.
35. Vymazal J, Zak O, Bulte JW, Aisen P, Brooks RA. TI and T2 of ferritin solutions: effect of loading factor. Magn. Reson. Med. 1996; 36: 61-65.
36. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 2005; 7: 109-117.
37. Genove G, DeMarco U, Xu H, Goins WF, Ahrens ET. A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med. 2005; 11: 450-454.